CB
55
-2
APA
23
-4
MUR
44
-4
PX
52
-3
IRM
73
-2
DVA
73
-4
HIG
68
-2
DHR
58
4
KMI
63
-6
PG
50
2
VRTX
53
3
V
38
4
TEL
66
6
TMO
60
6
EA
49
3
PLD
51
-2
ZTS
60
4
BXP
57
-2
UA
57
6
VRSK
38
-16
CB
55
-2
APA
23
-4
MUR
44
-4
PX
52
-3
IRM
73
-2
DVA
73
-4
HIG
68
-2
DHR
58
4
KMI
63
-6
PG
50
2
VRTX
53
3
V
38
4
TEL
66
6
TMO
60
6
EA
49
3
PLD
51
-2
ZTS
60
4
BXP
57
-2
UA
57
6
VRSK
38
-16
Financhill
Back

Amneal Pharmaceuticals 10K Form

Buy
69

AMRX
Amneal Pharmaceuticals

Last Price:
8.19
Seasonality Move:
8.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AMRX News And Ratings

See the #1 stock for the next 7 days that we like better than AMRX

AMRX Financial Statistics

Sales & Book Value

Annual Sales: $2.39B
Cash Flow: $28.2M
Price / Cash Flow: 12.22
Annual Sales: $-0.19
Price / Book: 0

Profitability

EPS (TTM): -0.62000
Net Income (TTM): $-174.62M
Gross Margin: $820.57M
Return on Equity: -233.7%
Return on Assets: -4.9%

Amneal Pharmaceuticals Earnings Forecast

Key Amneal Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 8 years for AMRX is 34.28%.
  • The Selling, General & Administrative Expenses for AMRX have been equal to 17.95% of Gross Profit Margin.
  • The Research & Development expenses have been 7.01% of Revenue.
  • The Interest Expense is -250.77% of Operating Income.
  • The Net Earning history of AMRX is -3.51% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

Amneal Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AMRX
CUSIP: 03168L
Website: amneal.com

Debt

Debt-to-Equity Ratio: -45.47
Current Ratio: 1.33
Quick Ratio: 0.76

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 11.97

AMRX Technical Analysis vs Fundamental Analysis

Buy
69
Amneal Pharmaceuticals (AMRX) is a Buy

Is Amneal Pharmaceuticals a Buy or a Sell?